#mRNA #RFKJr #Lysenkoism
"Cancelling mRNA studies is the highest irresponsibility
The rest of the world is not following the US government’s dangerous path, and will stick with the technology that helped the world out of the COVID-19 pandemic.
A technology that played a key part in saving millions of lives during the COVID-19 pandemic1 should be feted to the skies. Instead, US health secretary Robert F. Kennedy Jr announced last week that the US federal government is terminating 22 grants worth nearly US$500 million for projects researching messenger RNA (mRNA) vaccines.
This is the technology that, in his first term (2017–21), US President Donald Trump included in Operation Warp Speed: the federal government’s $18-billion programme to procure COVID-19 vaccines for US populations in record time2. It is also the technology that is showing potential for treating cancers3, autoimmune diseases and inherited conditions such as sickle cell disease. But now, in a statement accompanying the grant cancellations, Kennedy stated that 'these vaccines fail to protect effectively against upper respiratory infections like COVID and flu'. And in an article for The Washington Post, Jay Bhattacharya, director of the US National Institutes of Health, wrote that mRNA technology 'failed to earn the public’s trust', which fuelled vaccine hesitancy.
Shock and disbelief does not even begin to describe the reaction from mRNA and public-health researchers. The Alliance for mRNA Medicines, which represents companies and universities, said in a statement: 'Secretary Kennedy’s unscientific and misguided vilification of mRNA technology and cancellation of grants is the epitome of cutting off your nose to spite your face.'
True words. Yet this announcement is not unexpected. Kennedy’s views on vaccination are well known, and outside the research consensus. As Nature’s news team and others have reported for months, the Trump administration is busy removing independent specialists and replacing them with political appointments in many cases. This has happened in science and public-policy domains including health, economic statistics and the environment.
Often, where the world’s one-time science superpower has led, others have keenly followed. But not in this instance. There is no queue of countries lining up to adopt the Kennedy doctrine. One reason is that most countries appreciate that the mRNA manufacturing platform can be repurposed for different uses. Predicting how many vaccines to stockpile for an emergency has always been a huge headache for governments, as has been the cost of keeping manufacturing facilities open when they are not in use. With mRNA, when a platform isn’t being used to make vaccines, it will not just sit idle, racking up costs, but instead has the potential to be used to manufacture other therapeutics."
https://www.nature.com/articles/d41586-025-02612-9